Skip to main content
HR 4563 116th Congress House Crime and Law Enforcement Administrative remedies Congressional oversight Crime prevention Criminal investigation, prosecution, interrogation Department of Justice Drug trafficking and controlled substances Fraud offenses and financial crimes Health care coverage and access Licensing and registrations Medical education Prescription drugs Retail and wholesale trades

RESTORE Act of 2019

Introduced: September 27, 2019 Introduced by: Fitzpatrick, Brian K. Republican · Pennsylvania See on congress.gov
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 28, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Sep 30, 2019
Referred to the Subcommittee on Health.
Sep 27, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 27, 2019
Introduced in House
 Plain-English summary Congressional Research Service

Restoring Enforcement Standards to Track Opioids Responsively and Effectively Act of 2019 or the RESTORE Act of 2019

This bill repeals the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. That act modified the standards that the Drug Enforcement Administration must apply when deciding whether to deny, revoke, or suspend the registration of a manufacturer, distributor, or dispenser of controlled substances (i.e., substances regulated under federal law based on their medical use and potential for dependence and abuse).

What's happening now October 28, 2019

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

 Committees of jurisdiction 4